These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


464 related items for PubMed ID: 17392010

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM, Heckbert SR, Atkins D, Siscovick DS, Koepsell TD, Wahl PW, Longstreth WT, Weiss NS, Wagner EH, Prentice R.
    Arch Intern Med; 1993 Jun 28; 153(12):1421-7. PubMed ID: 8512434
    [Abstract] [Full Text] [Related]

  • 24. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K, Oger E.
    Rev Prat; 2005 Feb 28; 55(4):389-92. PubMed ID: 15828617
    [Abstract] [Full Text] [Related]

  • 25. Practical guidelines for postmenopausal hormone therapy.
    Speroff L, Kenemans P, Burger HG.
    Maturitas; 2005 May 16; 51(1):4-7. PubMed ID: 15883102
    [Abstract] [Full Text] [Related]

  • 26. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M.
    Ital Heart J Suppl; 2003 Jul 16; 4(7):545-58. PubMed ID: 14558283
    [Abstract] [Full Text] [Related]

  • 27. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L, Dell'Aniello S, Assouline S, Suissa S.
    BJOG; 2008 Jan 16; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [Abstract] [Full Text] [Related]

  • 28. Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk.
    Lobo RA.
    Maturitas; 2005 May 16; 51(1):98-109. PubMed ID: 15883114
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Benefits and risks in hormone substitute therapy in postmenopause].
    Baljić T.
    Srp Arh Celok Lek; 1996 May 16; 124(5-6):143-6. PubMed ID: 9102835
    [Abstract] [Full Text] [Related]

  • 31. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
    Bouaziz E, Canonico M, Verstuyft C, Carcaillon L, Martin F, Scarabin PY, Guiochon-Mantel A, EStrogen, THromboEmbolism Risk (ESTHER) Study Group.
    Maturitas; 2009 Oct 20; 64(2):136-8. PubMed ID: 19782484
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. WHI risks: any relevance to menopause management?
    Burger HG.
    Maturitas; 2007 May 20; 57(1):6-10. PubMed ID: 17368974
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Controversies over hormone replacement therapy. HRT as a risk factor of breast cancer in postmenopausal women.
    Licznerska BE, Baer-Dubowska W.
    Acta Pol Pharm; 2005 May 20; 62(3):241-7. PubMed ID: 16193819
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Estrogen and progestogen therapy in postmenopausal women.
    Practice Committee of the American Society for Reproductive Medicine.
    Fertil Steril; 2006 Nov 20; 86(5 Suppl 1):S75-88. PubMed ID: 17055850
    [No Abstract] [Full Text] [Related]

  • 38. Hormone therapy and breast cancer risk.
    Foidart JM, Desreux J, Pintiaux A, Gompel A.
    Climacteric; 2007 Oct 20; 10 Suppl 2():54-61. PubMed ID: 17882674
    [Abstract] [Full Text] [Related]

  • 39. Progestogens in postmenopausal hormone therapy and the risk of breast cancer.
    Lambrinoudaki I.
    Maturitas; 2014 Apr 20; 77(4):311-7. PubMed ID: 24485796
    [Abstract] [Full Text] [Related]

  • 40. Cancer issues.
    Marsden J, Sturdee D.
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb 20; 23(1):87-107. PubMed ID: 19036643
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.